Secondly, even if the prognostic significance of clinical variables such as serum albumin, line of treatment and number of metastatic sites could be expected in patients with advanced cancer it is of value establishing their relevance for the first time in a large population of patients treated with modern IMAs-based combinations within ep-CTs. This evidence concerns the gene ALB and cancer.